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Endoscopic resection (ER) has become a standard local 
therapy for early gastric cancer (EGC) without risk of lymph 
node metastasis (LNM). Although the indications for ER have 
been expanded to include undifferentiated-type histology, the 
usefulness of ER for undifferentiated EGC is still controver-
sial, likely because of its more aggressive behavior than differ-
entiated-type gastric cancer.1-3
Thus, a precise histological diagnosis before ER is import-
ant, especially for undifferentiated-type EGC. If differenti-
ated histology on prior biopsy is changed to undifferentiat-
ed-type histology after ER, the treatment strategy can also be 
changed.4 Most studies on the therapeutic outcomes of ER 
focused on histology after ER. However, in the clinical field, 
the final pathology after ER may unexpectedly be reported as 
undifferentiated-type histology.
Approximately 15% to 20% of patients with undifferen-
tiated-type EGC diagnosed after ER exhibit differentiated 
histology on biopsy prior to ER.4,5 Undifferentiated-type EGC 
exhibiting a differentiated histology on biopsy is more aggres-
sive and is associated with a lower curative resection (CR) rate 
than undifferentiated-type EGC, consistent with the biopsy 
pathology.4-6 These reasons likely explain why Bang et al. (in 
this issue of Clinical Endoscopy) analyzed therapeutic out-
comes of ER after dividing enrolled EGC into lesions with the 
expanded and beyond the expanded indications.7 According 
to their results, the histological type of 46.1% of the lesions on 
biopsy was other than undifferentiated-type histology.7 The 
histological findings varied from atypical cells to differenti-
ated histology. The CR rate after ER was lower than that of 
lesions with the expanded indications, consistent with pre-
vious reports. This result is probably to be expected because 
the criteria for CR are stricter for undifferentiated-type EGC 
than for other histologies. Thus, when precise histological di-
agnosis prior to ER is required, magnifying endoscopy (ME) 
with narrow-band imaging (NBI) can be helpful. In addition, 
the actual biopsy site may be more important than the num-
ber of biopsies.8 A previous study featuring histopathological 
mapping of undifferentiated-type EGC, which showed differ-
entiated histology on biopsy, found that the zone of transition 
from differentiated to undifferentiated histology was fre-
quently located at one or two peripheral sites of the lesion.4,8 
Thus, biopsy of several peripheral regions may assist in the 
diagnosis of undifferentiated-type histology prior to ER.4,8
ER is performed with reference to the Japanese classifica-
tion, that is, differentiated or undifferentiated-type histology. 
Poorly differentiated adenocarcinoma (PDA) and signet-ring 
cell carcinoma (SRC) are included within the undifferentiat-
ed-type histology. PDA is associated with higher LNM rates 
than other histological types of EGC, whereas SRC has a 
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lower LNM rate than other histological types of EGC.9-12 Thus, 
biological behaviors such as LNM differ between PDA and 
SRC, despite both being categorized as undifferentiated types 
of EGC.
However, when ER is performed according to current indi-
cations, the clinical outcomes of PDA and SRC do not differ 
significantly.13,14 Bang et al. also showed no significant differ-
ences between PDA and SRC in terms of immediate and long-
term outcomes.7 According to previous studies, the pattern of 
non-CR differs between PDA and SRC. Non-CR is associated 
with vertical margin involvement in PDA but lateral margin 
involvement in SRC.13,14 In the study of Bang et al., the pro-
portion of vertical margin involvement was higher in PDA, 
while that of lateral margin involvement was higher in SRC, 
albeit not significantly.7 Furthermore, PDA showed signifi-
cantly more submucosal invasion than SRC.7 Thus, the main 
considerations prior to ER can differ between PDA and SRC; 
prediction of tumor depth is important in PDA, whereas the 
extent of the lesion is important in SRC.8 To predict the extent 
of SRC, intramucosal spreading of cancer cells can be consid-
ered.15 The intramucosal spreading pattern of SRC can be cat-
egorized as expanding (epithelial spread) or infiltrative (sub-
epithelial spread).15 Moreover, infiltrative spread was greater 
in cases with lateral margin involvement and more prevalent 
than expanding spread in cases surrounded by atrophy and 
intestinal metaplasia.15 Therefore, larger ER safety margins 
may be necessary in cases of SRC with surrounding mucosa 
exhibiting atrophy or/and intestinal metaplasia, which can 
spread subepithelially to the margins.15 Predictions of tumor 
extension using ME with NBI is inaccurate in SRC, unlike in 
differentiated EGC.16,17 However, ME with NBI taking into 
consideration the pathologic growth pattern could facilitate 
the exact prediction of tumor extension in undifferentiat-
ed-type EGC.18 Thus, for CR of undifferentiated-type EGC by 
ER, it is important to consider the biological characteristics 
of cancer cells, not simply to perform advanced endoscopy 
techniques such as ME with NBI. After ER, if the tumor size 
is within the present expanded criteria for CR, it can be suffi-
cient for good clinical outcomes. In fact, one study investigat-
ed whether the risk of LNM or lymphovascular invasion (LVI) 
was increased when the difference in tumor size was >1 mm 
in comparison with the ER size criteria.19 The result showed 
that the risk of LNM or LVI was not increased when there 
was a >10-mm tumor size difference from the ER size criteria 
in the ulcer-negative intramucosal cancer with undifferentiat-
ed-type histology.19
Bang et al. stated that previous studies on the therapeutic 
outcomes of ER in undifferentiated-type EGC focused on 
post-ER histology, or included lesions that met only the ex-
panded indications or criteria, which might have overestimat-
ed the therapeutic outcomes.7 Thus, Bang et al. categorized 
the lesions according to pre/post ER and the expanded indica-
tions/criteria.7 The present analysis may be helpful by describ-
ing real-world experience of the therapeutic outcomes of ER 
in undifferentiated-type EGC, although the results were not 
different from those of previous reports. However, it had bet-
ter have provided readers more useful information, not ana-
lyzing simply therapeutic outcomes according to pre-/post ER 
and the expanded indication/criteria. The CR rate is low after 
ER in undifferentiated-type EGC according to many studies, 
including that by Bang et al.7 However, long-term therapeutic 
outcomes are acceptable if CR is performed. Nevertheless, the 
biological characteristics of undifferentiated-type EGC differ 
from those of differentiated EGC. Thus, the decision to per-
form ER in cases of undifferentiated-type EGC must be made 
carefully and in accordance with strict criteria based on the 
unique biological features of undifferentiated-type EGC.
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